Heart Failure Pathophysiology — MCQs
A 52-year-old woman has long-standing rheumatoid arthritis (RA) and is being treated with corticosteroids and nonsteroidal anti-inflammatory drugs (NSAIDs). Which of the following cardiac complications may arise in this clinical setting?
What is the physiological response of the kidney during shock?
High-output cardiac failure is seen in:
Which biomarker is typically elevated in the plasma of patients with chronic heart disease?
All drugs decrease mortality in heart failure except:
A 50-year-old patient presents with dyspnea, edema, and an elevated JVP. Which condition is most likely?
Which type of white blood cell plays a primary role in cardiac remodeling and chronic inflammation in heart failure?
Which of the following is a stain for heart failure cells?
Heart failure cells are
Concentric hypertrophy of left ventricle is seen in -
Heart Failure Pathophysiology Indian Medical PG Practice Questions and MCQs
Question 1: A 52-year-old woman has long-standing rheumatoid arthritis (RA) and is being treated with corticosteroids and nonsteroidal anti-inflammatory drugs (NSAIDs). Which of the following cardiac complications may arise in this clinical setting?
- A. Hypertrophic cardiomyopathy
- B. Restrictive cardiomyopathy
- C. Dilated cardiomyopathy
- D. Constrictive pericarditis (Correct Answer)
Explanation: ***Constrictive pericarditis*** - Chronic **inflammation** associated with rheumatoid arthritis can lead to pericardial involvement, often manifesting as **pericardial effusion** or **fibrosis**. [1] - Over time, this fibrosis can progress to **pericardial thickening** and calcification, impairing diastolic filling and causing symptoms of constrictive pericarditis. [1] *Hypertrophic cardiomyopathy* - This condition is characterized by **left ventricular hypertrophy** without an identifiable cause like hypertension or aortic stenosis. - It is primarily a **genetic disorder** of the sarcomere and is not typically associated with rheumatoid arthritis or its treatments. [2] *Restrictive cardiomyopathy* - Characterized by stiff, non-compliant ventricular walls that restrict diastolic filling, often due to **infiltrative diseases** like amyloidosis or sarcoidosis. [2] - While RA can cause amyloidosis, it is not the most direct or common cardiac complication, and this diagnosis focuses on myocardial stiffness rather than pericardial disease. [3, 4] *Dilated cardiomyopathy* - Involves **enlargement and weakening** of the heart ventricles, leading to impaired systolic function. - It can be caused by various factors including viral infections, alcohol, or genetic predisposition, but is not a typical direct cardiac complication of rheumatoid arthritis. [2]
Question 2: What is the physiological response of the kidney during shock?
- A. GFR decreases
- B. Perfusion of kidney decreases
- C. Afferent arteriole resistance increases
- D. Renal blood flow decreases (Correct Answer)
Explanation: ***Renal blood flow decreases*** - During shock, the **primary and most fundamental** physiological change affecting the kidney is a marked **reduction in renal blood flow (RBF)**. - Shock triggers intense **sympathetic activation** and **renin-angiotensin system (RAS) activation**, causing preferential **vasoconstriction** of renal vessels to redirect blood to vital organs (brain, heart). - RBF can drop to as low as **20-30% of normal** in severe shock, making this the hallmark renal response. - This reduction in RBF is the **upstream event** that triggers all other renal changes during shock. *Perfusion of kidney decreases* - While technically correct, "decreased perfusion" is **essentially synonymous** with decreased blood flow in this context. - The term "renal blood flow" is the **standard physiological terminology** used in medical literature to describe this phenomenon, making it the more precise answer. *Afferent arteriole resistance increases* - This is a **mechanism** by which RBF decreases, not the overall response itself. - Increased afferent arteriolar resistance is **secondary** to sympathetic activation and angiotensin II effects during shock. - It describes the "how" rather than the "what" of the kidney's response. *GFR decreases* - GFR reduction is a **consequence** of decreased RBF and increased afferent arteriolar resistance. - While clinically important (oliguria/acute kidney injury), it's a **downstream effect** rather than the primary physiological response. - The relationship: ↓RBF → ↓Glomerular hydrostatic pressure → ↓GFR
Question 3: High-output cardiac failure is seen in:
- A. Thyrotoxicosis (Hyperthyroidism) (Correct Answer)
- B. Heart failure with preserved ejection fraction (HFpEF)
- C. Cor pulmonale (Right heart failure due to pulmonary hypertension)
- D. Aortic stenosis (Obstruction to left ventricular outflow)
Explanation: ***Thyrotoxicosis (Hyperthyroidism)*** - High levels of thyroid hormones increase **basal metabolic rate** and cardiac output, leading to a state where the heart struggles to meet the body's excessive demands despite a normal or even elevated cardiac output. - This chronic state of increased cardiac workload can eventually lead to cardiac enlargement and **heart failure** despite good systolic function. *Heart failure with preserved ejection fraction (HFpEF)* - HFpEF is characterized by **diastolic dysfunction**, where the heart's pumping ability is normal but its relaxation and filling are impaired [1]. - While it represents a type of heart failure, it's typically understood as a **low-output state** or normal-output state relative to demand, not a high-output state caused by increased metabolic needs [2]. *Cor pulmonale (Right heart failure due to pulmonary hypertension)* - Cor pulmonale is **right ventricular failure** resulting from pulmonary hypertension, where the right side of the heart struggles to pump against increased resistance in the pulmonary circulation. - This condition is characterized by **elevated pulmonary vascular resistance** and often reduced cardiac output, not an intrinsic high-output state. *Aortic stenosis (Obstruction to left ventricular outflow)* - Aortic stenosis causes an **obstruction to blood flow** from the left ventricle, leading to increased pressure load on the left ventricle and eventual concentric hypertrophy. - This condition typically results in a **reduced or normal cardiac output** because of the outflow obstruction and is not considered a high-output state.
Question 4: Which biomarker is typically elevated in the plasma of patients with chronic heart disease?
- A. Endothelin-1
- B. Troponin T
- C. B-type natriuretic peptide (BNP) (Correct Answer)
- D. Cortisol
Explanation: ***B-type natriuretic peptide (BNP)*** - **BNP** is a hormone secreted by **ventricular cardiomyocytes** in response to increased wall stretch and pressure overload, making it a strong indicator of **myocardial stress** and **chronic heart failure** [1]. - Elevated levels correlate with the **severity of heart failure**, aiding in diagnosis and prognosis [1]. *Endothelin-1* - **Endothelin-1** is a potent **vasoconstrictor** involved in vascular tone regulation and endothelial dysfunction. - While it can be elevated in conditions like **pulmonary hypertension** and **atherosclerosis**, it is not a primary diagnostic biomarker for chronic heart disease in general. *Troponin T* - **Troponin T** is a cardiac-specific protein that is released into the bloodstream following **myocardial injury or necrosis**. - While it is a crucial biomarker for **acute coronary syndromes** (e.g., heart attack), persistently elevated levels are not typical for stable chronic heart disease unless there is ongoing subclinical myocardial damage. *Cortisol* - **Cortisol** is a **stress hormone** produced by the adrenal glands, involved in metabolism, immune response, and blood pressure regulation. - While chronic stress can impact cardiovascular health, cortisol itself is not a specific diagnostic biomarker for chronic heart disease.
Question 5: All drugs decrease mortality in heart failure except:
- A. Enalapril
- B. Metoprolol
- C. Digoxin (Correct Answer)
- D. Telmisartan
Explanation: ***Digoxin*** - **Digoxin** is known to improve symptoms and reduce hospitalizations in heart failure, but it has **not been shown to decrease mortality** in large clinical trials (DIG trial). - Its narrow **therapeutic window** and potential for toxicity, especially in patients with renal impairment, limit its use primarily to symptom management. *Metoprolol* - **Metoprolol succinate**, a beta-blocker, significantly reduces mortality and morbidity in patients with chronic heart failure with reduced ejection fraction (MERIT-HF trial) by blocking the deleterious effects of the sympathetic nervous system. - It works by reducing heart rate, myocardial oxygen demand, and cardiac remodeling. *Enalapril* - **Enalapril**, an ACE inhibitor, is a cornerstone medication in heart failure treatment due to its proven ability to reduce mortality, hospitalizations, and improve quality of life (CONSENSUS, SOLVD trials). - It works by blocking the **renin-angiotensin-aldosterone system**, leading to vasodilation, reduced preload and afterload, and prevention of cardiac remodeling. *Telmisartan* - **Telmisartan**, an ARB (angiotensin receptor blocker), is used as an alternative in heart failure patients who cannot tolerate ACE inhibitors due to side effects like cough. - ARBs as a class have shown mortality benefits in heart failure, acting by blocking the **angiotensin II type 1 receptor**, producing similar cardiovascular benefits to ACE inhibitors in terms of vasodilation and reduction in cardiac remodeling.
Question 6: A 50-year-old patient presents with dyspnea, edema, and an elevated JVP. Which condition is most likely?
- A. Right heart failure (Correct Answer)
- B. Left heart failure
- C. Pneumonia
- D. Asthma
Explanation: ***Right heart failure*** - **Dyspnea**, **edema** (often peripheral), and an **elevated jugular venous pressure (JVP)** are classical signs of right heart failure due to systemic venous congestion [1]. - The inability of the right ventricle to pump blood efficiently leads to blood backing up in the systemic circulation [3]. *Left heart failure* - While it can cause dyspnea, left heart failure primarily leads to **pulmonary congestion** (e.g., crackles, orthopnea) and is less directly associated with prominent peripheral edema and elevated JVP as initial prominent symptoms [2]. - An elevated JVP and significant peripheral edema in left heart failure typically indicate progression to **biventricular failure** [1]. *Pneumonia* - Pneumonia typically presents with acute symptoms like **fever, cough with sputum, pleuritic chest pain**, and localized lung findings, rather than chronic dyspnea, edema, and elevated JVP. - It’s an **infectious lung condition**, not primarily a circulatory disorder causing systemic congestion. *Asthma* - Asthma is a **reversible obstructive airway disease** characterized by episodic **wheezing, cough, and shortness of breath** due to bronchospasm [4]. - It does not typically cause edema or an elevated JVP.
Question 7: Which type of white blood cell plays a primary role in cardiac remodeling and chronic inflammation in heart failure?
- A. Eosinophils
- B. Macrophages (Correct Answer)
- C. T cells
- D. B cells
Explanation: ***Macrophages*** - **Macrophages** are increasingly recognized for their critical role in the pathogenesis and progression of **heart failure**, contributing to **cardiac remodeling**, chronic inflammation, and fibrosis - They infiltrate failing myocardium and play dual roles: promoting both **inflammation** and **tissue repair** - Their activation state (M1 vs M2 phenotypes) can significantly influence cardiac function and prognosis in heart failure patients - They secrete **cytokines**, **growth factors**, and **matrix metalloproteinases** that contribute to ventricular remodeling *Eosinophils* - **Eosinophils** are primarily involved in **allergic reactions** and defense against **parasitic infections** - While they can contribute to inflammation in specific cardiac conditions (e.g., **eosinophilic myocarditis**, **Loeffler endocarditis**), they are not primarily associated with the general pathophysiology of chronic heart failure *T cells* - **T cells** are central to **adaptive immunity**, including cell-mediated responses and modulation of immune reactions - Though T cells play a role in inflammatory processes in certain forms of heart disease, particularly **viral myocarditis**, they are not the predominant immune cell driving chronic cardiac remodeling in heart failure *B cells* - **B cells** are responsible for producing **antibodies** and are key players in humoral immunity - While B cells can contribute to autoimmune forms of heart disease and certain inflammatory processes, they are not typically the primary immune cell associated with the progression of chronic heart failure
Question 8: Which of the following is a stain for heart failure cells?
- A. PAS
- B. Prussian blue (Correct Answer)
- C. Sudan black
- D. Oil red O
Explanation: ***Prussian blue*** - Heart failure cells are **alveolar macrophages** that have phagocytosed **hemosiderin** (iron-laden pigment) from extravasated red blood cells due to **pulmonary congestion** in heart failure. - The **Prussian blue stain** specifically detects the ferric iron (Fe3+) within hemosiderin, making it the appropriate stain for identifying heart failure cells. *PAS* - **Periodic Acid-Schiff (PAS)** stain detects **carbohydrates** such as glycogen, mucins, and glycoproteins, and is used for conditions like **glycogen storage diseases** or certain fungal infections. - It does not specifically identify iron or hemosiderin, hence it is not used for heart failure cells. *Sudan black* - **Sudan black** is a **lipid stain** used to identify intracellular **lipids** and distinguish between different types of leukemia based on the presence of myeloperoxidase. - It is not designed to detect iron or hemosiderin and thus is not used for heart failure cells. *Oil red O* - **Oil Red O** is another common stain for demonstrating neutral **lipids** and triglycerides in frozen tissue sections. - Like Sudan black, it is a lipid stain and therefore would not be helpful in identifying the iron-laden hemosiderin characteristic of heart failure cells.
Question 9: Heart failure cells are
- A. Lipofuscin granules in cardiac cells
- B. Pigmented alveolar macrophages (Correct Answer)
- C. Pigmented pancreatic acinar cells
- D. Pigment cells seen in liver
Explanation: ***Pigmented alveolar macrophages*** - These macrophages engulf **hemosiderin** (iron-rich pigment from degraded red blood cells) that leaks into the alveoli due to increased capillary pressure in left-sided **heart failure**. - The presence of **hemosiderin-laden macrophages** in the sputum or lung tissue is diagnostic for chronic pulmonary congestion caused by heart failure. *Lipofuscin granules in cardiac cells* - **Lipofuscin** is a "wear-and-tear" pigment that accumulates in aging cells, including cardiac cells. - While present in older hearts, its presence does not specifically indicate **heart failure** or represent "heart failure cells" in the described context. *Pigmented pancreatic acinar cells* - Pancreatic acinar cells primarily produce digestive enzymes and are not typically associated with **pigment accumulation** in the context of heart failure. - Pigmentation in pancreatic cells would suggest other pathologies, such as **hemochromatosis** affecting the pancreas. *Pigment cells seen in liver* - The liver can accumulate various pigments, such as **hemosiderin** in hemochromatosis or **bilirubin** in cholestasis. - While liver congestion can occur in right-sided heart failure, the specific "heart failure cells" refer to the **pulmonary macrophages**.
Question 10: Concentric hypertrophy of left ventricle is seen in -
- A. Congenital aortic stenosis due to bicuspid aortic valve (Correct Answer)
- B. Mitral Stenosis
- C. Aortic Regurgitation
- D. Hypertrophic Obstructive Cardiomyopathy
Explanation: ***Congenital aortic stenosis due to bicuspid aortic valve*** - **Aortic stenosis** creates a **pressure overload** on the left ventricle, leading to a compensatory increase in myocardial wall thickness without significant chamber dilation, which is the classic example of **concentric hypertrophy** [1]. - A **bicuspid aortic valve** is a common congenital anomaly that causes aortic stenosis and thus concentric left ventricular hypertrophy [2]. - This represents **acquired concentric hypertrophy** due to hemodynamic stress. *Mitral Stenosis* - **Mitral stenosis** primarily causes a pressure overload on the **left atrium**, leading to left atrial enlargement [3]. - While it can indirectly affect the left ventricle, it typically does not cause **concentric left ventricular hypertrophy** itself. *Aortic Regurgitation* - **Aortic regurgitation** leads to a **volume overload** on the left ventricle as blood flows back into the ventricle during diastole. - This typically results in **eccentric hypertrophy**, where both the ventricular wall thickness and chamber size increase significantly (dilated ventricle with increased mass) [1]. *Hypertrophic Obstructive Cardiomyopathy* - **Hypertrophic obstructive cardiomyopathy (HOCM)** is a **primary genetic myocardial disease** characterized by **asymmetric septal hypertrophy** rather than uniform concentric hypertrophy. - While HOCM involves significant myocardial hypertrophy, it represents a distinct pathophysiologic entity with **asymmetric distribution** (predominantly septal), not the classic concentric pattern seen with pressure overload states. - The hypertrophy in HOCM is **intrinsic (genetic)** rather than **adaptive (hemodynamic)** like in aortic stenosis. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Heart, p. 536. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Heart, pp. 562-563. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of Infancy and Childhood, pp. 533-534.
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free